Type 1 diabetes is now accepted to be a chronic immunoinflammatory disorder. Because it is a disease of inflammation—both of the innate and adaptive immune systems—it is perhaps not surprising that ...
Authorization advances Fractyl Health to a dual clinical-stage company, with Revita® in pivotal development for post-GLP-1 ...
After nearly 100 years of development, treatments that bolster the body's immune system to fight cancer are coming of age – and saving patients' lives.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results